Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Confirmed: AFib ablation more beneficial for patients with HFrEF than those with HFpEF
Researchers explored data from nearly 2,500 AFib ablation patients, sharing their findings in JAMA Cardiology.
American Heart Association thinks pharmacists can play a bigger role in AFib care
Pharmacists interact with patients on a regular basis and are seen as a trusted source of health information. Can they help cardiologists improve care for AFib patients?
2 out of 5 AFib patients develop heart failure later in life
Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat.
FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy
The new gene therapy candidate is now one step closer to being approved by the FDA.
Cardiologist-approved VR for interventional procedures headed to ACC.24
San Francisco-based Osso VR and the American College of Cardiology have collaborated on advanced LAAO simulations. The two groups first started working together back in 2022.

Hoping to improve care for these patients, Hermann et al. turned to the ŌNŌ retrieval system, a catheter-delivered device cleared by the U.S. Food and Drug Administration in 2022. The device was developed by Ōnōcor, a U.S. healthcare startup with roots in the Penn Center for Innovation.

Cardiologists are first in world to remove unstable Watchman devices with FDA-cleared retrieval system

A team of specialists in Houston made history, using the new-look device to treat three patients over the age of 80. The group shared its experience in JACC: Clinical Electrophysiology.

March 19, 2024

Adults who regularly drink sweetened beverages face a heightened risk of atrial fibrillation (AFib), according to new data published in Circulation: Arrhythmia and Electrophysiology.

Heart issues more common in adults who drink soda, other sweetened beverages

Diet sodas made with artificial sweeteners are associated with an even higher risk of issues than sugar-sweetened sodas.

March 12, 2024

Permanent pacemaker implantation after TAVR increases healthcare costs by $24,000 per patient

Researchers say their new analysis, based on five years of U.S. data, highlights just how important it is to keep post-TAVR PPMI rates to a minimum.

March 5, 2024

Biosense Webster gained CE mark approval for its Varipulse pulsed field ablation (PFA) system in Europe

Biosense Webster gains CE mark approval for new PFA system

The news represents yet another big regulatory approval for PFA technology in 2024. Could FDA approval be next for Biosense Webster?

February 29, 2024

Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston.

Biosense Webster funding new PFA research

The VIRTUE and POLARIS studies are both focused on evaluating how the Varipulse PFA Platform performs in a variety of clinical scenarios.

February 8, 2024

Former NBA champion, Survivor contestant now fighting for his life as he waits for a heart transplant

Scot Pollard has a long family history of heart disease, and he’s been on a watch list for several years now due to his size. He's been in and out of hospitals for more than three years due to an ongoing fight with cardiomyopathy.

February 8, 2024

Medtronic shared new STROKE AF data on the Reveal Linq ICM

Medtronic ICM a cost-effective approach for reducing the risk of ischemic stroke

Remote monitoring with the Reveal Linq insertable cardiac monitor can improve outcomes without breaking the bank, according to new data being presented at the International Stroke Conference in Phoenix.

February 7, 2024

Biosense Webster shares latest data on its pulsed field ablation system

The company, part of Johnson & Johnson MedTech, shared positive data from two different clinical trials at AF Symposium 2024 in Boston.

February 5, 2024

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Electrophysiology

Confirmed: AFib ablation more beneficial for patients with HFrEF than those with HFpEF

American Heart Association thinks pharmacists can play a bigger role in AFib care

2 out of 5 AFib patients develop heart failure later in life

FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy

Cardiologist-approved VR for interventional procedures headed to ACC.24

Around the web